EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Injectable Platelet-Rich Fibrin in Orthopedics: Where Do We Stand?

Fábio Ramos Costa iD, Sergio Augusto Lopes de Souza iD, Rubens Andrade Martins iD, Bruno Ramos Costa, Luyddy Pires iD, Alex Pontes de Macedo iD, Napoliane Santos iD, Stephany Cares Huber, Gabriel Silva Santos, André Kruel iD, Márcia Santos, José Fábio Lana

Current Issues in Molecular Biology · 29.03.2025 · 47 (4) · 239

DOI: 10.3390/cimb47040239 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 29.03.2025. Verfasst von Fábio Ramos Costa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, FC Sports Traumatology, Salvador 40296-210, BA, Brazil. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Injectable Platelet-Rich Fibrin (i-PRF) has emerged as a promising tool in regenerative medicine, particularly in orthopedics, due to its unique biological properties and ease of preparation. i-PRF is an autologous platelet concentrate derived through a simple, anticoagulant-free centrifugation process, resulting in a liquid matrix enriched with fibrin, leukocytes, and growth factors. These components promote tissue regeneration, angiogenesis, and anti-inflammatory responses, making i-PRF suitable for bone and cartilage repair as well as drug delivery systems. This review discusses the history, biological mechanisms, and clinical applications of i-PRF in orthopedics, highlighting its potential advantages over traditional platelet-rich plasma (PRP). Furthermore, we address the challenges and limitations of i-PRF, including drug stability, release control, and bioactive interactions, underscoring the need for further research to optimize its therapeutic efficacy.

Schlagwörter

Stichwörter der Autor:innen

anti-inflammatory therapyorthopedicsplatelet-rich fibrinregenerative medicinetissue regeneration

Autor:innen und Institutionen

  • Department of Orthopedics, FC Sports Traumatology, Salvador 40296-210, BA, Brazil.
  • Department of Radiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-916, RJ, Brazil.
  • Medical School, Tiradentes University Center, Maceió 57038-000, AL, Brazil.
  • Medical School, Zarns College, Salvador 41720-200, BA, Brazil.
  • Department of Orthopedics, Brazilian Institute of Regenerative Medicine (BIRM), Indaiatuba 13334-170, SP, Brazil.
  • Regenerative Medicine, Orthoregen International Course, Indaiatuba 13334-170, SP, Brazil.

ORCID-Profile: Fábio Ramos Costa, Sergio Augusto Lopes de Souza, Rubens Andrade Martins, Luyddy Pires, Alex Pontes de Macedo, Napoliane Santos, André Kruel

Zitieren

APA

Costa, F. R., de Souza, S. A. L., Martins, R. A., Costa, B. R., Pires, L., de Macedo, A. P., Santos, N., Huber, S. C., Santos, G. S., Kruel, A., Santos, M., & Lana, J. F. (2025). The Role of Injectable Platelet-Rich Fibrin in Orthopedics: Where Do We Stand?. Current Issues in Molecular Biology, 47(4), 239. https://doi.org/10.3390/cimb47040239

Vancouver

Costa FR, de Souza SAL, Martins RA, Costa BR, Pires L, de Macedo AP, et al. The Role of Injectable Platelet-Rich Fibrin in Orthopedics: Where Do We Stand?. Current Issues in Molecular Biology. 2025;47(4):239. doi:10.3390/cimb47040239

BibTeX
@article{Costa2025,
  author = {Costa, Fábio Ramos and de Souza, Sergio Augusto Lopes and Martins, Rubens Andrade and Costa, Bruno Ramos and Pires, Luyddy and de Macedo, Alex Pontes and Santos, Napoliane and Huber, Stephany Cares and Santos, Gabriel Silva and Kruel, André and Santos, Márcia and Lana, José Fábio},
  title = {The Role of Injectable Platelet-Rich Fibrin in Orthopedics: Where Do We Stand?},
  journal = {Current Issues in Molecular Biology},
  year = {2025},
  volume = {47},
  number = {4},
  pages = {239},
  doi = {10.3390/cimb47040239}
}
Kostenlos starten →